|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/15/13 Biolase, Inc 10-K 12/31/12 76:8.5M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.11M
2: EX-21.1 Subsidiaries List HTML 20K
3: EX-23.1 Consent of Experts or Counsel HTML 22K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 26K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 26K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 22K
7: EX-32.2 Certification -- §906 - SOA'02 HTML 23K
52: R1 Document and Entity Information HTML 53K
41: R2 Consolidated Balance sheets HTML 144K
50: R3 Consolidated Balance sheets (Parenthetical) HTML 51K
54: R4 Consolidated Statements of Operations and HTML 121K
Comprehensive Loss
70: R5 Consolidated Statements of Shareholders' Equity HTML 97K
(Deficit)
43: R6 Consolidated Statements of Cash Flows HTML 180K
49: R7 Basis Of Presentation HTML 42K
37: R8 Summary Of Significant Accounting Policies HTML 97K
28: R9 Supplementary Balance Sheet Information HTML 67K
71: R10 Intangible Assets And Goodwill HTML 52K
56: R11 Lines Of Credit And Other Borrowings HTML 36K
55: R12 Income Taxes HTML 87K
61: R13 Commitments And Contingencies HTML 38K
62: R14 Stockholders' Equity HTML 108K
59: R15 Segment Information HTML 37K
63: R16 Concentrations HTML 25K
51: R17 Non-Recurring Event HTML 25K
53: R18 Subsequent Events HTML 23K
58: R19 Schedule II-Consolidated Valuation and Qualifying HTML 41K
Accounts and Reserves
76: R20 Basis Of Presentation (Policies) HTML 242K
66: R21 Summary Of Significant Accounting Policies HTML 59K
(Tables)
46: R22 Supplementary Balance Sheet Information (Tables) HTML 72K
57: R23 Intangible Assets And Goodwill (Tables) HTML 43K
48: R24 Income Taxes (Tables) HTML 84K
22: R25 Commitments And Contingencies (Tables) HTML 26K
67: R26 Stockholders' Equity (Tables) HTML 83K
73: R27 Segment Information (Tables) HTML 30K
32: R28 Schedule II-Consolidated Valuation and Qualifying HTML 39K
Accounts and Reserves (Tables)
31: R29 Basis of Presentation - Additional Information HTML 55K
(Detail)
35: R30 Estimated Useful Lives Of Property, Plant and HTML 28K
Equipment (Detail)
36: R31 Summary of Significant Accounting Policies - HTML 98K
Additional Information (Detail)
38: R32 Accrued Liabilities - Changes In Initial Product HTML 41K
Warranty Accrual and Expenses Under Initial and
Extended Warranties (Detail)
20: R33 Classification Of Compensation Expense Associated HTML 32K
With Share-Based Payments (Detail)
64: R34 Assumptions Used in Estimating Fair Value Of Stock HTML 34K
Options Granted (Detail)
45: R35 Components of Accounts Receivable, Net of HTML 30K
Allowance (Detail)
47: R36 Supplementary Balance Sheet Information - HTML 52K
Additional Information (Detail)
25: R37 Components of Inventory (Detail) HTML 34K
75: R38 Summary of Property,Plant and Equipment (Detail) HTML 39K
14: R39 Components of Accrued Liabilities (Detail) HTML 50K
39: R40 Summary of Deferred Revenue (Detail) HTML 40K
69: R41 Intangible Assets And Goodwill - Additional HTML 47K
Information (Detail)
24: R42 Intangible Assets Related to Accumulated HTML 54K
Amortization and Goodwill (Detail)
30: R43 Lines Of Credit And Other Borrowings - Additional HTML 128K
Information (Detail)
34: R44 Summary of Income Tax Current and Deferred HTML 65K
Provision (Benefit) (Detail)
42: R45 Federal Income Tax Provision Compared With HTML 63K
Statutory Rates (Detail)
19: R46 Summary of Net Deferred Tax Assets and Net HTML 83K
Deferred Tax Liabilities (Detail)
27: R47 Income Taxes - Additional Information (Detail) HTML 61K
16: R48 Summary of Unrecognized Tax Benefits (Detail) HTML 31K
68: R49 Commitments And Contingencies - Additional HTML 38K
Information (Detail)
23: R50 Future Minimum Rental Commitments Under Operating HTML 45K
Lease Agreements (Detail)
65: R51 Stockholders' Equity - Additional Information HTML 163K
(Detail)
26: R52 Summary of Option Activity (Detail) HTML 83K
40: R53 Options Outstanding and Exercisable (Detail) HTML 70K
15: R54 Cash Proceeds Along With Fair Value Disclosures HTML 41K
Related to grants Exercises And Vesting Options
(Detail)
17: R55 Segment Information - Additional Information HTML 32K
(Detail)
33: R56 Summary of Net Revenue by Geographic Location HTML 27K
(Detail)
21: R57 Concentrations - Additional Information (Detail) HTML 36K
72: R58 Non Recurring Event - Additional Information HTML 36K
(Detail)
44: R59 Subsequent Events - Additional Information HTML 30K
(Detail)
60: R60 Consolidated Valuation and Qualifying Accounts and HTML 36K
Reserves (Detail)
74: XML IDEA XML File -- Filing Summary XML 115K
29: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 1.02M
8: EX-101.INS XBRL Instance -- biol-20121231 XML 1.69M
10: EX-101.CAL XBRL Calculations -- biol-20121231_cal XML 251K
11: EX-101.DEF XBRL Definitions -- biol-20121231_def XML 1.09M
12: EX-101.LAB XBRL Labels -- biol-20121231_lab XML 1.77M
13: EX-101.PRE XBRL Presentations -- biol-20121231_pre XML 1.22M
9: EX-101.SCH XBRL Schema -- biol-20121231 XSD 255K
18: ZIP XBRL Zipped Folder -- 0001193125-13-110112-xbrl Zip 218K
| EX-31.1 |
Exhibit 31.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Federico Pignatelli, certify that:
1. I have reviewed this Annual Report on Form 10-K of BIOLASE, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the Registrant as of, and for, the periods presented in this report;
4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;
b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s fourth fiscal quarter ended December 31, 2012 that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of Registrant’s board of directors (or persons performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize, and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
| Date: March 15, 2013 | ||
| By: |
||
| Federico Pignatelli | ||
| Chief Executive Officer | ||
| (Principal Executive Officer) | ||
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/15/13 | None on these Dates | ||
| For Period end: | 12/31/12 | |||
| List all Filings | ||||